✦ LIBER ✦

Evaluation of the Combination 5-Fluorouracil, Dacarbazine, and Epirubicin in Patients With Advanced Well-Differentiated Neuroendocrine Tumors

✍ Scribed by Thomas Walter; Domitille Bruneton; Philippe A. Cassier; Valérie Hervieu; Frank Pilleul; Jean Yves Scoazec; Jean Alain Chayvialle; Catherine Lombard-Bohas

Book ID: 119935255
Publisher: CIG Media Group, LP.
Year: 2010
Tongue: English
Weight: 130 KB
Volume: 9
Category: Article
ISSN: 1533-0028
DOI: 10.3816/ccc.2010.n.037

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5-fluorouracil, dacarbazine, and epirubi

5-fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors

✍ Emilio Bajetta; Lorenza Rimassa; Carlo Carnaghi; Ettore Seregni; Leonardo Ferrar 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

The authors thank the Italian Trials in Medical Oncology (I.T.M.O.) group for their assistance with statistical analysis and preparation of the manuscript.

An EORTC gastrointestinal group phase II

An EORTC gastrointestinal group phase II evaluation of epirubicin combined with 5-fluorouracil in advanced adenocarcinoma of the pancreas

✍ Wils, J.; Bleiberg, H.; Dalesio, O.; Duez, N.; Blijham, G.; Planting, A.; Splint 📂 Article 📅 1987 🏛 Elsevier Science ⚖ 160 KB

Phase I dose-escalation study of tezacit

Phase I dose-escalation study of tezacitabine in combination with 5-fluorouracil in patients with advanced solid tumors

✍ Johanna C. Bendell; Joseph P. Eder; Jeffrey W. Clark; Panagiotis Fidias; Thomas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 3 views

Pharmacokinetics of escalating doses of

Pharmacokinetics of escalating doses of CCI-779 in combination with 5-fluorouracil and leucovorin in patients with advanced solid tumors

✍ J. Boni; J. Korth-Bradley; C.J.A. Punt; A. Hanauske; K. Weigang-Köhler; C. Thiel 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A randomized Phase III trial of etoposid

A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma

✍ Fikri İçli; İsmail Çelik; Faruk Aykan; Aytuǧ Üner; Ahmet Demirkazik; Ahmet Özet; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## BACKGROUND. Gastric carcinoma is a substantial health problem in Turkey, and the majority of patients present with inoperable disease. The aim of this randomized trial was to assess the activity of 5-fluorouracil versus etoposide when combined with epirubicin plus cisplatin in patients with adv

A phase I study of escalating doses of C

A phase I study of escalating doses of CCI-779 in combination with 5-fluorouracil and leucovorin in patients with advanced solid tumors

✍ C.J.A. Punt; U. Bruntsch; A.-R. Hanauske; K. Weigang-Köhler; M. Peters; C. Thiel 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 171 KB